Sarah Seager, MS

Senior Director, Analytics & AI
IQVIA, United Kingdom

Poster(s):

• (029) Prevalence of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (161) DARWIN EU® - Real-World Evaluation of Pulmonary Arterial Hypertension Treatment and Outcomes in Europe
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (174) Impact of Cardiovascular Medications on Non-Traumatic Amputation Rates in Type 2 Diabetes: Insights from a Large-Scale Retrospective Real-World Data Analysis
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (247) DARWIN EU® - Characterization of Patients with Chronic Hepatitis B and C
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (259) Evaluating the Incidence and Burden of Gestational Diabetes in the United States: A Retrospective Study (2015-2022)
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (314) Treatment of systemic lupus erythematosus: analysis of treatment patterns in adult and paediatric patients across four European countries
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (315) Treatments of multiple myeloma in Europe from 2012 to 2022: a population-based network cohort study
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (BSPOT33) Natural history of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST